Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$72.89

3.07 (4.40%)

, CCL

Carnival

$51.93

0.16 (0.31%)

10:08
11/23/16
11/23
10:08
11/23/16
10:08

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Analog Devices (ADI) upgraded to Buy from Neutral at BofA Merrill Lynch, with analyst Vivek Arya saying Analog's solid fourth quarter alleviates prior concerns regarding sales growth, Apple/consumer exposure, and Linear Technology (LLTC) accretion. 2. Carnival (CCL) upgraded to Outperform from Market Perform at Bernstein, with analyst David Beckel saying the company's results and forward trends have shown "remarkable stability." 3. Autoliv (ALV) upgraded to Neutral from Sell at Goldman with the firm citing valuation. 4. Bank of Montreal (BMO) upgraded to Neutral from Underperform at Credit Suisse with analyst Nick Stogdill citing a moderation in its premium valuation and leverage to rising U.S. interest rates. 5. EdR (EDR) upgraded to Buy from Neutral at BofA Merrill Lynch, with analyst Jeffrey Spector saying EdR has a strong balance sheet and growth, with a low risk development pipeline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ADI

Analog Devices

$72.89

3.07 (4.40%)

CCL

Carnival

$51.93

0.16 (0.31%)

ALV

Autoliv

$100.99

-0.82 (-0.81%)

BMO

Bank of Montreal

$66.00

0.29 (0.44%)

EDR

EdR

$39.91

-0.15 (-0.37%)

  • 28

    Nov

ADI Analog Devices
$72.89

3.07 (4.40%)

11/16/16
MSCO
11/16/16
NO CHANGE
Target $78
MSCO
Overweight
Morgan Stanley positive on Analog Devices ahead of earnings and into 2017
Morgan Stanley analyst Craig Hettenbach said Analog Devices (ADI) is one of his top Overweight picks and sees upside to earnings for the next 2 quarters given strength in broad-based markets and strong opex controls. The analyst expects October quarterly earnings of 90c and $942M, in line with consensus, to prove to be conservative and sees meaningful accretion from the Linear Technology (LLTC) deal adding 84c to 2018 earnings and believes cost savings of $150M will prove to be too low.
11/22/16
OPCO
11/22/16
NO CHANGE
Target $85
OPCO
Outperform
Analog Devices price target raised to $85 from $80 at Oppenheimer
Oppenheimer analyst Rick Schafer said Analog Devices' better than expected earnings and guidance show the company is executing at a high level and noted that its Linear Technology acquisition is on track to close in Q2. The analyst raised his price target on the stock to $85 from $80 and keeps an Outperform rating on Analog Devices shares.
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
Analog Devices upgraded to Buy from Neutral at BofA/Merrill
11/23/16
11/23/16
UPGRADE
Target $85

Buy
Analog Devices upgraded to Buy on sales growth, accretion at BofA/Merrill
As previously reported, BofA/Merrill upgraded Analog Devices (ADI) to Buy from Neutral and raised its price target to $85 from $70. Analyst Vivek Arya said Analog's solid Q4 alleviates prior concerns regarding sales growth, Apple/consumer exposure, and Linear Technology (LLTC) accretion. Arya believes the Linear acquisition will create a powerful, diversified, and profitable vendor and is forecasting $5+ in FY18 free cash flow.
CCL Carnival
$51.93

0.16 (0.31%)

10/27/16
JPMS
10/27/16
DOWNGRADE
Target $73
JPMS
Neutral
Royal Caribbean downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Joseph Greff downgraded Royal Caribbean (RCL) to Neutral saying he does not see a "meaningful fundamental turn" in net yields and pricing for the cruise lines. The analyst lowered his price target for the shares to $73 from $96. Greff this morning also downgraded Norwegian Cruise Line (NCLH) to Neutral and kept a Neutral rating on Carnival (CCL) with a reduced price target of $46.
11/01/16
11/01/16
NO CHANGE

Royal Caribbean, cruise sector poised to outperform, says Wells Fargo
After Royal Caribbean (RCL) reaffirmed its 2016 guidance and 2017 targets, Wells Fargo thinks that investors are beginning to regain confidence in the cruise sector, The firm expects the sector to outperform through at least early 2017, and it keeps an Outperform rating on Royal Caribbean. Other companies in the sector include Carnival (CCL) and Norwegian Cruise Line (NCLH).
11/22/16
BERN
11/22/16
UPGRADE
BERN
Outperform
Carnival upgraded to Outperform from Market Perform at Bernstein
11/23/16
BERN
11/23/16
UPGRADE
BERN
Outperform
Carnival upgraded on results, initiatives at Bernstein
As noted earlier, Bernstein upgraded Carnival to Outperform from Market Perform. Analyst David Beckel says that the company's results and forward trends have shown "remarkable stability." He thinks that its initiatives will cause its demand to increase and boost its yields. Target to $68 from $52.
ALV Autoliv
$100.99

-0.82 (-0.81%)

07/25/16
BARD
07/25/16
NO CHANGE
Target $131
BARD
Outperform
Autoliv weakness a buying opportunity, says Baird
Baird said the weakness in Autoliv created an attractive entry point for long-term investors. The firm remains buyers of the shares as they believe the near-term outlook was clouded by its Q2 miss and lower guidance. Baird expects investors to return to the stock given the company's elevated spending levels to support long-term organic growth. Baird reiterated its Outperform rating and lowered its price target to $131 from $137 on Autoliv shares.
10/28/16
BARD
10/28/16
DOWNGRADE
BARD
Neutral
Autoliv downgraded to Neutral from Outperform at Baird
10/28/16
BARD
10/28/16
DOWNGRADE
Target $104
BARD
Neutral
Autoliv downgraded to Neutral at Baird
As reported previously, Baird analyst David Leiker downgraded Autoliv to Neutral from Outperform as organic sales and earnings growth slow on legacy roll-offs in the active safety business. Leiker lowered his price target to $104 from $129 on Autoliv shares.
11/23/16
GSCO
11/23/16
UPGRADE
Target $95
GSCO
Neutral
Autoliv upgraded to Neutral from Sell at Goldman
Goldman upgraded Autoliv to Neutral citing valuation and lowered its price target to $95 from $101.
BMO Bank of Montreal
$66.00

0.29 (0.44%)

09/21/16
DUND
09/21/16
INITIATION
DUND
Neutral
Bank of Montreal initiated with a Neutral at Dundee
10/04/16
FBCO
10/04/16
DOWNGRADE
FBCO
Underperform
Bank of Montreal downgraded to Underperform from Neutral at Credit Suisse
11/01/16
BOFA
11/01/16
INITIATION
Target $66
BOFA
Neutral
Bank of Montreal reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Ebrahim Poonawala reinstated Bank of Montreal with a Neutral and a $66 price target.
11/23/16
FBCO
11/23/16
UPGRADE
FBCO
Neutral
Bank of Montreal upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Nick Stogdill upgraded Bank of Montreal to Neutral due to a moderation in its premium valuation and leverage to rising U.S. interest rates.
EDR EdR
$39.91

-0.15 (-0.37%)

10/31/16
10/31/16
NO CHANGE

EdR reports Q3 Core FFO 4c, may not compare to consensus 28c
Reports Q3 revenue $66.23M, consensus $62.09M.
11/17/16
HDLY
11/17/16
UPGRADE
HDLY
Neutral
EdR upgraded to Neutral from Underperform at Hilliard Lyons
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
EdR upgraded to Buy from Neutral at BofA/Merrill
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
EdR upgraded to Buy on growth at BofA/Merrill
As previously reported, BofA/Merrill upgraded EdR from Neutral and maintained its $46 price target. Analyst Jeffrey Spector said EdR has a strong balance sheet and growth, with a low risk development pipeline.

TODAY'S FREE FLY STORIES

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.